Congratulations to Juan Song who is a Recipient of the 2019 Outstanding Faculty Mentor Award from the UNC Office of Postdoctoral Affairs! This is one of two mentoring awards she has received this year!
Congratulations to Wesley Legant for being selected as a recipient of one of the National Institutes of Health 93 awards to fund highly innovative, high-impact biomedical research as part of its High-Risk, High-Reward Research Program!
The technique, dubbed VEGAS and created in the lab of Bryan L. Roth, works in mammalian cells and can yield useful new molecules within days, providing scientists with a powerful new research tool and a potential route to better therapeutics for various diseases.
The UNC-Chapel Hill Office of the Vice Chancellor for Research announced the 2019 Creativity Hubs Awards to accelerate solutions to societal challenges. Hub team members include Lee Graves, John Sondek and Shawn Gomez.
Wesley Legant, PhD, assistant professor in the departments of Pharmacology and Biomedical Engineering, earned this prestigious early career award for his work developing new fluorescence microscopes for rapid three-dimensional imaging.
Researchers in the UNC Lineberger Comprehensive Cancer Center led by Lee Graves, PhD, have uncovered the mechanism that explains how an investigational cancer therapeutic might be working.
Dr. Gary L. Johnson, Kenan Distinguished Professor and former chair of the Department of Pharmacology retired at the end of May after 16 years with the department, 13 of which he was the Department Chair.
Congratulations to Wesley Legant, PhD, who has been named a Searle Scholar! The award comes with $300,000 of support funding over three years.
Pharmacology celebrates Bryan Roth’s election today to the American Academy of Arts and Sciences, the country’s oldest academy. We congratulate Bryan for receiving this prestigious honor!
In lab experiments, researchers led by Michael Emanuele, PhD, found that the enzyme USP21 protects the protein FOXM1, which has been implicated in basal-like breast cancer progression, metastasis, and poor patient outcomes.
